How Much Does DMEPOS Accreditation Cost? — Complete 2026 Guide

Last updated: April 2026

Total first-year cost for a single DMEPOS location: approximately $8,000–$26,500+, combining consulting fees ($4,500–$18,000+), accrediting organization survey fees ($1,855–$7,000+), and the $750 CMS enrollment application fee. Annual ongoing costs under the 2026 survey mandate run $2,000–$10,000+ per year. The cost of non-compliance — an 18-month Medicare billing suspension plus civil monetary penalties exceeding $25,000 — makes accreditation investment straightforward risk management.

DMEPOS Accreditation Consulting Overview | FAQ | ACHC vs. BOC vs. TCT Comparison

CMS-Approved Accrediting Organization Fee Structures (2026)

Every DMEPOS supplier pays both accrediting organization fees and the CMS enrollment application fee. AO fees vary by organization and are paid directly to the AO. The CMS fee is paid separately through PECOS.

CMS Medicare Enrollment Application Fee

The CMS Medicare Enrollment Application Fee for CY 2026 is $750. This applies to initial applications, revalidations, and new location additions — paid directly to CMS. It is non-waivable and applies regardless of which AO you use. (Source: CMS DMEPOS Accreditation Guidance)

ABC (American Board for Certification in O&P/Pedorthics) — Published 2026 Fee Schedule

ABC is the only major CMS-approved DMEPOS AO that publishes a transparent fee schedule. 2026 rates:

ABC is particularly well-suited for O&P clinics, pedorthists, and orthotics specialists. Its transparent fee structure makes total cost predictable before engagement.

ACHC (Accreditation Commission for Health Care) — Custom Quote

ACHC does not publish a standard fee schedule. Fees are quoted based on organizational size, patient volume, and product categories. General ranges based on 2026 market data:

ACHC is the most widely used DMEPOS accreditor and the recommended primary option for most suppliers in 2026 — particularly those in CA, FL, NY, or TX where BOC is blocked, and for organizations transitioning from BOC.

The Compliance Team (TCT) — Custom Quote

TCT uses a similar custom quoting model to ACHC. Fee ranges are broadly comparable. TCT's primary differentiator is its real-time web-based compliance portal, which adds operational value for the ongoing documentation requirements of the 2026 annual survey mandate. The portal may carry a subscription component in addition to standard survey fees — confirm with TCT during initial inquiry.

All Other CMS-Approved AOs

CHAP, TJC, HQAA, NABP, BOC, and DNV Healthcare each use custom quoting. NABP is typically the most cost-efficient path for pharmacies billing limited DMEPOS categories, as it covers both pharmacy and certain DMEPOS billing in a single credential — eliminating dual-track accreditation costs.

Multi-Location Fee Structure

Each physical DMEPOS location requires its own survey and accreditation — there is no portfolio or umbrella accreditation that covers multiple locations under a single fee. For organizations with 5+ locations, IHS structures phased engagement timelines that stagger survey submissions to manage both cost and staff bandwidth. Total multi-location cost scales roughly linearly with location count, though some AOs offer reduced per-location fees for high-volume clients.

DMEPOS Accreditation Consulting Engagement Costs

Full accreditation preparation consulting for a single location runs $4,500–$18,000+ depending on documentation maturity, organizational complexity, product category mix, and state licensing requirements. Annual retainer engagements for continuous readiness under the 2026 annual survey mandate run $1,000–$5,000 per year. Hourly regulatory affairs work runs $120–$450 per hour (Premium Consulting Corp publishes $120/hour as the market floor).

What Drives Consulting Cost Higher

• Zero documentation baseline — organizations with no existing P&P require full policy development from scratch, adding 2–4 weeks and $3,000–$6,000+ to Phase 2
• Complex product categories — respiratory therapy, complex rehab technology, and pharmacy-based DMEPOS billing require more specialized documentation and staff training than standard HME
• Multi-state operations — Florida, Texas, California, and Illinois each impose state-level licensing requirements that must be managed in parallel with federal accreditation; each state adds process complexity and timeline risk
• AO transition (BOC to ACHC/TCT) — transition engagements require mapping existing documentation to new AO standards and addressing gap items before re-survey
• M&A context — deals requiring 36-month rule analysis and PECOS re-enrollment strategy add legal/regulatory advisory complexity beyond standard accreditation preparation
• Prior survey failures — organizations with a prior failed survey require remediation of cited deficiencies plus rebuilding surveyor confidence through comprehensive mock survey preparation

What Is Included in an IHS DMEPOS Engagement

• Gap assessment and baseline audit against CMS Quality Standards and target AO standards
• Prioritized remediation plan with timeline and staff assignment recommendations
• Complete customized P&P manual development for your specific product categories
• Staff training on HIPAA, FWA, OSHA, patient equipment instruction — with compliant documentation logs
• Unannounced mock survey with tracer exercises and written findings report
• Application submission support and deposit management
• Plan of Correction preparation if deficiencies are cited at live survey
• CMS-855S preparation and PECOS enrollment support through first Medicare claim
• State licensing guidance for FL, TX, CA, IL when applicable

Annual Retainer: Continuous Compliance Under the 2026 Survey Mandate

The January 1, 2026 annual survey mandate eliminated the viability of ad hoc triennial preparation. IHS annual retainer engagements at $1,000–$5,000/year include: mid-year documentation review and update, policy currency verification against AO standards updates, annual staff training coordination, complaint log audit, and mock survey readiness assessment before the annual survey window. For organizations billing more than $2 million annually in Medicare, the retainer cost is a fraction of the internal FTE cost it supplements or replaces.

Internal Resource Requirements

Organizations with more than $2 million in annual Medicare billing require 0.5 to 1.0 dedicated FTE focused on Quality Assurance and Performance Improvement (QAPI) under the 2026 annual survey mandate. This internal compliance officer role manages: continuous lot tracking, peer review audits, staff competency assessments, complaint logs, TB record currency, and annual leadership policy reviews. The role did not exist as a full-time function in most DMEPOS organizations under the pre-2026 triennial model.

FTE Cost Estimate

A 0.5 FTE healthcare compliance coordinator at median salary ($55,000–$75,000 annual for a qualified candidate in most markets) represents $27,500–$37,500/year in direct compensation, plus benefits. A 1.0 FTE compliance officer at $65,000–$90,000/year represents $65,000–$90,000 in direct costs. IHS annual retainer engagements at $1,000–$5,000/year are best understood as a supplement to internal FTE — not a replacement. The retainer provides the expert review layer; the internal FTE manages daily operations.

DIY vs. Consultant: Where the Math Breaks Down

Some organizations attempt DMEPOS accreditation without consulting support. The failure economics are straightforward: documentation errors cause 60% of failed surveys. (Source: NikoHealth 2026) A first-time applicant managing their own accreditation preparation faces an approximately 60% risk of documentation-related citation at the live survey — triggering a Plan of Correction delay of 30–90 days, a potential re-survey fee, and delayed Medicare enrollment. For an organization with $100,000/month in projected Medicare revenue, each month of delayed enrollment represents $100,000 in unrealized billings. A $12,000 consulting investment that reduces survey failure risk and compresses the timeline by 6 weeks typically pays back within the first Medicare billing cycle.

Under the 2026 annual survey mandate, the stakes of survey failure have increased: an 18-month Medicare billing suspension following accreditation revocation was survivable under the triennial model (where the gap between surveys was 3 years). Under the annual model, a supplier that fails their survey and loses accreditation faces 18 months of suspended billing followed immediately by a re-accreditation requirement before the next annual survey. The cumulative revenue impact is existential for most independent suppliers.

ROI of DMEPOS Accreditation — and of Getting It Right the First Time

Revenue at Risk Without Accreditation

DMEPOS accreditation is a binary Medicare billing requirement — not an optional credential. Without active accreditation, the organization cannot submit Medicare claims for any covered DMEPOS item. For organizations deriving 60–80% of revenue from Medicare (typical for traditional HME/DME suppliers), the loss of accreditation is effectively the loss of the business. The ROI calculation is not "consulting cost vs. accreditation value" — it is "consulting cost vs. the cost of being unable to operate."

Competitive Bidding Program 2028 — Accreditation as Market Access

Only accredited DMEPOS suppliers may submit bids in the CMS Competitive Bidding Program (CBP). The 2028 CBP round bid window opens Late Summer/Early Fall 2026. Categories include Class II CGMs/Insulin Pumps, Urological/Ostomy Supplies, and OTS Braces. CMS projects awarding approximately 10 national CGM contracts and 8 urological contracts. A supplier that fails accreditation in 2026 is excluded from CBP until the next round — which may be most of a decade away. For suppliers in covered categories, maintaining accreditation in 2026 is the difference between competitive market access and permanent exclusion from the most lucrative Medicare contracting vehicle. [citation needed for CBP projections]

Cost of Survey Failure

A failed DMEPOS survey triggers: Plan of Correction requirement (30–90 day delay), potential re-survey fee ($1,000–$3,500+), delayed Medicare enrollment, and — under the annual mandate — increased surveyor scrutiny at the next annual survey. IHS mock surveys consistently identify 2–4 items that would have been cited in the live survey. The mock survey fee is typically $1,500–$3,000 as a component of the consulting engagement — less than one re-survey fee, and far less than one month of delayed Medicare enrollment for most suppliers.

Cost of Civil Monetary Penalties

Civil monetary penalties for billing Medicare while unaccredited exceed $25,000 per incident. (Source: NikoHealth 2026) For organizations that inadvertently allow accreditation to lapse and continue billing — a risk heightened under the annual survey mandate when the survey window is shorter — CMP exposure can rapidly exceed six figures. The IHS annual retainer explicitly includes accreditation currency monitoring to prevent inadvertent lapse.

State Licensing Revenue Protection

In Florida, Texas, California, and Illinois, federal accreditation is necessary but not sufficient. A supplier that achieves federal accreditation but fails to complete state licensing cannot bill in those states. Florida requires an in-state registered agent, local site inspection, and a surety bond exceeding $50,000. Texas requires a Device Distributor License through DSHS. California requires HMDR licensing at approximately $1,509 annually. Illinois requires a 10–12 week regulatory process and a bond of $10,000–$50,000. IHS manages state licensing requirements in parallel with federal accreditation — preventing the scenario where a supplier receives federal accreditation but cannot bill in its target states for months due to incomplete state licensing.

M&A Value Protection Under the 36-Month Rule

For buyers in DMEPOS M&A transactions, the 36-month ownership transfer rule makes accreditation status a material deal term. A target supplier with active, survey-current accreditation under a stable AO (ACHC or TCT) commands a premium over a target with lapsed accreditation, a pending CAP, or BOC accreditation requiring AO transition. IHS M&A due diligence engagements quantify accreditation risk as a deal-value component — one that buyers frequently fail to price correctly without specialist support. A $10,000 accreditation due diligence engagement that identifies an 18-month billing suspension risk in the target returns that fee within the first renegotiation conversation.

Total Cost Summary: First Year and Ongoing

State licensing costs excluded from totals above — add FL/TX/CA/IL costs when applicable. FTE costs are opportunity costs, not direct consulting fees.

Frequently Asked Questions — DMEPOS Accreditation Costs

How much does DMEPOS accreditation cost in 2026?

Total first-year cost for a single location: approximately $8,000–$26,500+ combining consulting fees ($4,500–$18,000+), AO survey fees ($1,855–$7,000+), and the $750 CMS enrollment application fee. Annual ongoing costs under the 2026 survey mandate: $2,000–$10,000+ per year in AO renewal fees and consulting retainer. State licensing adds cost in FL, TX, CA, and IL.

What is the CMS enrollment application fee for DMEPOS suppliers?

$750 for CY 2026. Applies to initial applications, revalidations, and new location additions. Paid directly to CMS through PECOS. Non-waivable regardless of AO choice. (Source: CMS DMEPOS Accreditation Guidance)

What is the annual cost of maintaining DMEPOS accreditation under the 2026 survey mandate?

Annual AO survey/renewal fee: $1,000–$5,000+. Annual retainer consulting: $1,000–$5,000/year. Internal FTE for organizations over $2M Medicare billing: $27,500–$90,000+/year (0.5–1.0 FTE). The 2026 annual survey mandate permanently shifted DMEPOS compliance from a triennial project cost to an ongoing operating cost.

What is the cost of losing DMEPOS accreditation?

18-month Medicare billing suspension — for a $3M/year supplier that is $4.5M in lost revenue. Civil monetary penalties exceeding $25,000 for billing while unaccredited. Full re-accreditation plus PECOS re-enrollment costs. The financial exposure from accreditation failure dwarfs any compliance investment by orders of magnitude. (Sources: NikoHealth 2026; CMS)

What affects the cost of DMEPOS accreditation consulting?

Primary cost drivers: documentation maturity at engagement start, number of locations, product category complexity (respiratory and complex rehab cost more), state licensing requirements (FL/TX/CA/IL add parallel process costs), and accreditation type (first-time vs. renewal vs. AO transition). IHS scopes each engagement individually based on a gap assessment before quoting.

Does hiring a DMEPOS accreditation consultant actually save money?

Yes, in most scenarios. Documentation errors cause 60% of survey failures. A failed survey delays Medicare enrollment — each month of delayed billing is lost revenue. A $15,000 consulting investment that prevents a 2-month enrollment delay for a supplier projecting $200,000/month in Medicare billing pays back in under 45 days. Under the 2026 annual survey mandate, the cost of getting it wrong — an 18-month billing suspension — has increased substantially relative to pre-2026 stakes.

What does PECOS Medicare enrollment cost after DMEPOS accreditation?

The $750 CMS enrollment application fee covers PECOS enrollment — no additional Medicare fee applies. However, the gap between federal processing mandate (50 calendar days) and actual Novitas backlog (3–6 months in practice) represents months of delayed billing that can exceed $100,000 in unrealized revenue for a mid-size supplier. IHS monitors PECOS status and escalates delays — the monitoring service pays for itself if it compresses enrollment by even 2–3 weeks. [citation needed for Novitas backlog data]

Get a Cost Estimate for Your DMEPOS Accreditation

IHS scopes every engagement with a gap assessment before quoting. You receive a specific cost estimate based on your actual documentation baseline, product categories, and state exposure — not a generic range. There is no obligation to proceed beyond the gap assessment.

Contact IHS: |

Related pages: DMEPOS Accreditation Consulting Overview | FAQ | ACHC vs. BOC vs. TCT Comparison | Client Case Study

Adjacent services: Home Health & Hospice Accreditation